Showing results (141-150 of 176) with videos related to
Sort By:
Pageof 18
Molecules (Basel, Switzerland)|April 23, 2022
Losartan Interactions with 2-Hydroxypropyl-β-CDVasiliki Palli, Georgios Leonis, Nikoletta Zoupanou, et al.Biomolecules|September 27, 2025
Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43Spyridon Marios Giatro, George Komontachakis, Aikaterini Kalantidou, et al.Biology|November 27, 2024
A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor PathwayPanagiotis Ntavaroukas, Konstantinos Michail, Rafaela Tsiakalidou, et al.Viruses|February 28, 2023
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and InfectivityHarry Ridgway, Charalampos Ntallis, Christos T Chasapis, et al.Journal of Chemical Information and Modeling|March 5, 2009
Antihypertensive drug valsartan in solution and at the AT1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking, and molecular dynamics simulationsConstantinos Potamitis, Maria Zervou, Vassilis Katsiaras, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonistsPanagiota Roumelioti, Ludmila Polevaya, Panagiotis Zoumpoulakis, et al.Journal of Molecular Graphics & Modelling|October 1, 2015
Elucidation of the binding mechanism of renin using a wide array of computational techniques and biological assaysHaralambos Tzoupis, Georgios Leonis, Aggelos Avramopoulos, et al.International Journal of Molecular Sciences|May 13, 2023
Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 TherapeuticsKonstantinos Kelaidonis, Irene Ligielli, Spiros Letsios, et al.Drug Research|June 1, 2017
In vitro Controlled Release from Solid Pharmaceutical Formulations of two new Adamantane Aminoethers with Antitubercular Activity (I)Marilena Vlachou, Angeliki Siamidi, Evanthia Diamantidi, et al.Bioorganic & Medicinal Chemistry|October 9, 2012
Conformational analysis of two novel cytotoxic C2-substituted pyrrolo[2,3-f]quinolines in aqueous media, organic solvents, membrane bilayers and at the putative active siteNicole Varvarigou, Grigorios Megariotis, Georgios Leonis, et al.Pageof 18